-
1
-
-
0027968516
-
Biologic effects of leukocytes present in transfused cellular blood products
-
Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:1703-1721, 1994.
-
(1994)
Blood
, vol.84
, pp. 1703-1721
-
-
Bordin, J.O.1
Heddle, N.M.2
Blajchman, M.A.3
-
2
-
-
0025086915
-
Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions
-
Brubaker DB: Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions. Transfusion 30:733-737, 1990.
-
(1990)
Transfusion
, vol.30
, pp. 733-737
-
-
Brubaker, D.B.1
-
3
-
-
0027385498
-
A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusion
-
Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG: A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusion. Transfusion 33:794-797, 1993.
-
(1993)
Transfusion
, vol.33
, pp. 794-797
-
-
Heddle, N.M.1
Klama, L.N.2
Griffith, L.3
Roberts, R.4
Shukla, G.5
Kelton, J.G.6
-
4
-
-
0028117243
-
Cytokine generation in stored platelet concentrates
-
Stack G, Snyder EL: Cytokine generation in stored platelet concentrates. Transfusion 34.20-25, 1994.
-
(1994)
Transfusion
, vol.34
, pp. 20-25
-
-
Stack, G.1
Snyder, E.L.2
-
5
-
-
0022374475
-
Diagnostic and pathogenic considerations in transfusion-related acute lung injury
-
Popovsky MA, Moore SB: Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 25:573-577, 1985.
-
(1985)
Transfusion
, vol.25
, pp. 573-577
-
-
Popovsky, M.A.1
Moore, S.B.2
-
6
-
-
0025287023
-
Transfusion-associated graft-versus-host disease
-
Anderson KC, Weinstein HJ: Transfusion-associated graft-versus-host disease. N Engl J Med 323:315-318, 1990.
-
(1990)
N Engl J Med
, vol.323
, pp. 315-318
-
-
Anderson, K.C.1
Weinstein, H.J.2
-
7
-
-
0028344060
-
Leukocyte reduction of cellular blood components -effectiveness, benefits, quality control, and costs
-
Lane AT: Leukocyte reduction of cellular blood components -effectiveness, benefits, quality control, and costs. Arch Pathol Lab Med 118:392-405, 1994.
-
(1994)
Arch Pathol Lab Med
, vol.118
, pp. 392-405
-
-
Lane, A.T.1
-
8
-
-
0006466935
-
Effectiveness of leukocyte depleted platelets in preventing febrile reactions in multitransfused oncology patients
-
abstract
-
Stec N, Kicker TS, Ness PM, Braine HG: Effectiveness of leukocyte depleted platelets in preventing febrile reactions in multitransfused oncology patients. Transfusion 26:569 (abstract), 1986.
-
(1986)
Transfusion
, vol.26
, pp. 569
-
-
Stec, N.1
Kicker, T.S.2
Ness, P.M.3
Braine, H.G.4
-
9
-
-
0024384069
-
Prevention of transfusion-acquired cytomegalovirus infections in infants by blood filtration to remove leukocytes
-
Gilbert GL, Hayes K, Hudson IL, et al.: Prevention of transfusion-acquired cytomegalovirus infections in infants by blood filtration to remove leukocytes. Lancet 1:1228-1231, 1989.
-
(1989)
Lancet
, vol.1
, pp. 1228-1231
-
-
Gilbert, G.L.1
Hayes, K.2
Hudson, I.L.3
-
10
-
-
0024404896
-
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products
-
De Graan-Heutzen YCE, Gratama JW, Mudle GC, et al.: Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 29:757-760, 1989.
-
(1989)
Transfusion
, vol.29
, pp. 757-760
-
-
De Graan-Heutzen, Y.C.E.1
Gratama, J.W.2
Mudle, G.C.3
-
11
-
-
0025851442
-
Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant
-
Bowden RA, Slichter JJ, Sayers MH, Mori M, Clays MJ, Meyers JD: Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 78:246-250, 1991.
-
(1991)
Blood
, vol.78
, pp. 246-250
-
-
Bowden, R.A.1
Slichter, J.J.2
Sayers, M.H.3
Mori, M.4
Clays, M.J.5
Meyers, J.D.6
-
12
-
-
0023726965
-
Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration
-
Andreu G, Dewailly J, Leberre C, et al.: Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 72:964-969, 1988.
-
(1988)
Blood
, vol.72
, pp. 964-969
-
-
Andreu, G.1
Dewailly, J.2
Leberre, C.3
-
13
-
-
0024700245
-
Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion
-
Meryman HT: Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion. Transf Med Rev 3:180-193, 1989.
-
(1989)
Transf Med Rev
, vol.3
, pp. 180-193
-
-
Meryman, H.T.1
-
14
-
-
0025139048
-
Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components
-
Saarinen UM, Kekomaki R, Siimes MA, Myllyla G: Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 75:512-517, 1990.
-
(1990)
Blood
, vol.75
, pp. 512-517
-
-
Saarinen, U.M.1
Kekomaki, R.2
Siimes, M.A.3
Myllyla, G.4
-
15
-
-
0026074494
-
Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial
-
Van Marwijk Kooy M, Van Prooijen HC, Moes M, Bosma-Stands I, Akkerman JWN: Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood 77:201-205, 1991.
-
(1991)
Blood
, vol.77
, pp. 201-205
-
-
Van Marwijk Kooy, M.1
Van Prooijen, H.C.2
Moes, M.3
Bosma-Stands, I.4
Akkerman, J.W.N.5
-
16
-
-
0028146602
-
Effect of white cell reduction on the resistance of blood components to bacterial multiplication
-
Buchholz DH, Aubuchon JP, Snyder EL, et al.: Effect of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 34:852-857, 1994.
-
(1994)
Transfusion
, vol.34
, pp. 852-857
-
-
Buchholz, D.H.1
Aubuchon, J.P.2
Snyder, E.L.3
-
17
-
-
0028855831
-
Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage
-
Aye MT, Palmer DS, Giulivi A, Hashemi S: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 35:117-124, 1995.
-
(1995)
Transfusion
, vol.35
, pp. 117-124
-
-
Aye, M.T.1
Palmer, D.S.2
Giulivi, A.3
Hashemi, S.4
-
19
-
-
0026646865
-
Validation of a simple method to count very low white cell concentrations in filtered red cells or platelets
-
Masse M, Naegelun C, Pellegrini N, Segier JM, Marpaux N, Benjean F: Validation of a simple method to count very low white cell concentrations in filtered red cells or platelets. Transfusion 32:565-571, 1992.
-
(1992)
Transfusion
, vol.32
, pp. 565-571
-
-
Masse, M.1
Naegelun, C.2
Pellegrini, N.3
Segier, J.M.4
Marpaux, N.5
Benjean, F.6
-
20
-
-
0028107053
-
Evaluation of apheresis platelet concentrates collected with a reduced (30-ml) collection chamber with resuspension and storage in a synthetic medium
-
Holme S, Heaton WA, Smith KT, Buchholz DH: Evaluation of apheresis platelet concentrates collected with a reduced (30-ml) collection chamber with resuspension and storage in a synthetic medium. Vox Sang 67:149-153, 1994.
-
(1994)
Vox Sang
, vol.67
, pp. 149-153
-
-
Holme, S.1
Heaton, W.A.2
Smith, K.T.3
Buchholz, D.H.4
-
21
-
-
0028650739
-
PLT-30: An improvement for platelet collection on the Baxter CS-3000 Plus
-
Nussbaumer W, Plattner R, Schoppel W, et al.: PLT-30: an improvement for platelet collection on the Baxter CS-3000 Plus. J Clin Apheresis 9:236-239, 1994.
-
(1994)
J Clin Apheresis
, vol.9
, pp. 236-239
-
-
Nussbaumer, W.1
Plattner, R.2
Schoppel, W.3
|